Sarepta Therapeutics Inc (STU:AB3A) Stock News, Headlines & Updates
Sarepta Therapeutics Inc Stock News from GuruFocus
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Jul 19, 2025
Sarepta Therapeutics Inc (SRPT) Responds to FDA Request to Halt ELEVIDYS Shipments | SRPT stock news
GuruFocus News • 8:01pm
Sarepta Therapeutics Provides Statement on ELEVIDYS
Business Wire • 7:00pm
Jul 18, 2025
SRPT Shareholders Have the Right to Lead the Sarepta Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - SRPT
PRNewswire • 5:00pm
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PRNewswire • 5:00pm
SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Marketwired • 3:01pm
SRPT BREAKING NEWS: Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Announces Third Death -- Contact BFA Law by the August 25 Class Action Deadline
Marketwired • 3:01pm
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Business Wire • 3:01pm
Sarepta (SRPT) Faces Halt on Elevidys Shipments by FDA | SRPT Stock News
GuruFocus News • 12:45pm
Sarepta (SRPT) Shares Plummet as FDA Halts Elevidys Shipments | SRPT Stock News
GuruFocus News • 12:45pm
FDA Requests Sarepta (SRPT) Halt Elevidys Shipments | SRPT Stock News
GuruFocus News • 12:45pm
Third Fatal Liver Failure Hits Sarepta Gene Trial
Undercovered Deep Insights • 12:39pm
Sarepta (SRPT) Trading Resumes: Key Insights for Investors | SRPT Stock News
GuruFocus News • 12:15pm
Sarepta (SRPT) Trading Halted Due to Volatility | SRPT Stock News
GuruFocus News • 12:15pm
Sarepta (SRPT) Faces Scrutiny Following Gene Therapy Concerns | SRPT Stock News
GuruFocus News • 11:45am
FDA Scrutiny Intensifies Over Sarepta's (SRPT) Elevidys Following Third Fatality | SRPT Stock News
GuruFocus News • 11:30am
Sarepta (SRPT) Faces Setback After Gene Therapy-Related Fatality | SRPT Stock News
GuruFocus News • 11:15am
Sarepta (SRPT) Downgraded by Needham Analyst | SRPT Stock News
GuruFocus News • 11:15am
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT
Marketwired • 11:00am
Sarepta Therapeutics (SRPT) Faces Stock Dip Amid Patient Death Disclosure | SRPT Stock News
GuruFocus News • 10:15am
Sarepta Therapeutics (SRPT) Price Target Lowered by B of A Securities | SRPT Stock News
GuruFocus News • 10:00am
Sarepta (SRPT) Faces Price Target Cut Amid Safety Concerns | SRPT Stock News
GuruFocus News • 9:15am
Sarepta (SRPT) Faces Pressure Amid Safety Concerns from Third Patient Death | SRPT Stock News
GuruFocus News • 9:15am
Sarepta (SRPT) Faces Investor Concerns Over Trial Transparency | SRPT Stock News
GuruFocus News • 8:46am
Sarepta (SRPT) Withholds Information on Gene Therapy Patient Death Amid Restructuring | SRPT Stock News
GuruFocus News • 8:45am
Sarepta Therapeutics (SRPT) Maintains Rating, Price Target Adjusted | SRPT Stock News
GuruFocus News • 8:31am
Sarepta (SRPT) Faces Increased Scrutiny After Gene Therapy Program Setback | SRPT Stock News
GuruFocus News • 8:31am
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc.(SRPT) Shareholders
PRNewswire • 8:00am
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Marketwired • 8:00am
Oppenheimer Adjusts Price Target for Sarepta (SRPT) Amid Strategic Updates | SRPT Stock News
GuruFocus News • 7:15am
Sarepta (SRPT) Shares Plummet 33% Following Study Setback | SRPT Stock News
GuruFocus News • 6:47am
Sarepta (SRPT) Faces Setback After Gene Therapy Trial Fatality | SRPT Stock News
GuruFocus News • 6:47am
SRPT INVESTOR DEADLINE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
PRNewswire • 6:00am
Sarepta (SRPT) Faces Scrutiny After Third Death Linked to Gene Therapy
GuruFocus News • 3:56am
Jul 17, 2025
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit
PRNewswire • 6:00pm
SRPT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Marketwired • 5:00pm
Sarepta Therapeutics, Inc. Sued for Securities Law Violations -- Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights -- SRPT
Marketwired • 4:00pm
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- SRPT
Marketwired • 3:00pm
Sarepta Therapeutics (SRPT) Price Target Revised Downward by Wells Fargo | SRPT Stock News
GuruFocus News • 11:03am
Sarepta Therapeutics (SRPT) Sees Target Price Increase by Barclays | SRPT Stock News
GuruFocus News • 10:32am
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Show
Entries
Headlines
Total 0- 1
No recent news